Castrate-Metastatic Prostate Cancer: Therapeutic Considerations for Advanced Disease

VOORHEES, N.J., April 22 /PRNewswire/ -- Castrate-refractory prostate cancer (CRPC), which is characterized by tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Standardized guidelines for the treatment of CRPC are lacking, and a number of factors must be considered when deciding between second-line hormonal therapy and chemotherapy. There are also a number of therapies being investigated in clinical trials for CRPC. It is critical for healthcare professionals involved in the care of patients with CRPC to understand and utilize the current optimal methods for defining and treating this condition, as well as be aware of emerging therapies under investigation.

To address the need for current education on CRPC, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing education virtual lecture titled Castrate-Metastatic Prostate Cancer: Therapeutic Considerations for Advanced Disease. The content of this virtual lecture is derived from a live webcast that took place on March 25, 2010. This activity, which is supported by educational grants from sanofi-aventis and Genentech, is certified for physicians, pharmacists, and nurses.

Robert Dreicer, MD, MS, FACP, Chairman of the Department of Solid Tumor Oncology at the Taussig Cancer Institute at the Cleveland Clinic and Professor of Medicine at the Cleveland Clinic Lerner College of Medicine in Cleveland, Ohio serves as faculty for this virtual lecture.

Healthcare professionals can visit www.ProstateEducation.com to access this free continuing education activity.

RMEI is a medical education company that specializes in independent, continuing medical education designed for clinicians to improve and deliver quality medical care to patients. The goal of RMEI educational offerings is to promote continuous professional development and the improvement of health outcomes. RMEI works closely with medical experts to develop activities that improve diagnosis and treatment leading to better outcomes for patients. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.

For other educational opportunities, please visit www.rmei.com.

SOURCE Robert Michael Educational Institute LLC